SELLAS Life Sciences Group, Inc.
USD13.97
-1.48 (-9.58%)
CEO
Angelos Stergiou
IPO Date
2008-03-12
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$15.22
Prev. Close
$15.45
Day Low
$13.34
Day High
$15.88
52W Low
$1.39
52W High
$15.87
Market Cap
$2.60B
Volume
11.24M
| 50,000 |
| $0.00 |
| 9 Jan 2026 | VAN NOSTRAND ROBERT L | director | A-Award | Acquired | 50,000 | $0.00 |
| 9 Jan 2026 | SCHEINBERG DAVID A | director | A-Award | Acquired | 50,000 | $0.00 |
| 9 Jan 2026 | CICIC DRAGAN | SVP, Chief Development Officer | A-Award | Acquired | 300,000 | $0.00 |
| 9 Jan 2026 | Burns John Thomas | CFO | A-Award | Acquired | 300,000 | $0.00 |
| 9 Jan 2026 | Kalin Katherine Bach | director | A-Award | Acquired | 50,000 | $0.00 |
| 9 Jan 2026 | Wasman Jane | director | A-Award | Acquired | 50,000 | $0.00 |
| 5 Dec 2025 | CICIC DRAGAN | SVP, Chief Development Officer | J-Other | Disposed | 63,800 | $1.50 |
| 5 Dec 2025 | Burns John Thomas | CFO | J-Other | Disposed | 58,592 | $1.50 |